← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2012Last known activity
Nov 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 9 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06396858OfficialPhase 4Nov 30, 2024
- NCT06396858Lead sponsorPhase 4Nov 30, 2024
- NCT06627530OfficialPhase 4Oct 31, 2024
- NCT06627530Lead sponsorPhase 4Oct 31, 2024
- NCT04641338Lead sponsorPhase 3Jan 31, 2022
- NCT04746339Study chairPhase 4Mar 4, 2021
- NCT04746339Lead sponsorPhase 4Mar 4, 2021
- NCT04757857CollaboratorPhase 4Sep 29, 2020
- NCT04394377Lead sponsorPhase 4May 31, 2020
- NCT04394377Study chairPhase 4May 31, 2020
- NCT04403685CollaboratorPhase 3May 8, 2020
- NCT01543555Study chairPhase 3Nov 1, 2012
- NCT01448642Study chairPhase 4Apr 1, 2012
Details
- Last known activity
- Nov 30, 2024